Dopaminergic Systems and Their Regulation 1986
DOI: 10.1007/978-1-349-07431-0_17
|View full text |Cite
|
Sign up to set email alerts
|

Behavioural Compensation after Dopamine Grafts in Brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 0 publications
0
10
0
Order By: Relevance
“…The dopamine (DA) molecule is a major CNS neurotransmitter that has been the focus of extensive study due to its prominent involvement in core behavioral processes – including motor control, motivation, learning, and memory – and contribution to several neuropsychiatric disorders – including Parkinson’s disease, schizophrenia, and drug addiction (Iversen et al, 2010). DA influences behavioral output by modulating basal ganglia circuit function.…”
Section: Introductionmentioning
confidence: 99%
“…The dopamine (DA) molecule is a major CNS neurotransmitter that has been the focus of extensive study due to its prominent involvement in core behavioral processes – including motor control, motivation, learning, and memory – and contribution to several neuropsychiatric disorders – including Parkinson’s disease, schizophrenia, and drug addiction (Iversen et al, 2010). DA influences behavioral output by modulating basal ganglia circuit function.…”
Section: Introductionmentioning
confidence: 99%
“…Midbrain dopaminergic (mDA) neurons in this group are implicated in emotional behavior, motivational functions, and reward mechanisms (2)(3)(4). On the other hand, SNc neurons mainly project to the dorsal striatum and regulate motor function (5). mDA neurons are of major interest in biomedical research because degeneration of SNc mDA neurons is the hallmark of Parkinson's disease (6).…”
mentioning
confidence: 99%
“…Many types of studies related to disorders including drug abuse, schizophrenia, Parkinson’s disease, and perhaps eating disorders, attention deficithyperactivity disorder, Tourette’s syndrome, and Lesch-Nyhan syndrome, which may involve dopaminergic systems (Iversen et al, 2009) could be enhanced through this use of this model, as compared to the use of mDA neurons in isolation. For example, hPSC-derived mDA neurons have been used as a model of MPP+ toxicity and GDNF protection (Zeng et al, 2006), but MPP+ toxicity is known to involve the fine terminal arborization of mDA terminals in the striatum, which occur only in the presence of appropriate synaptic targets of mDA neurons as well (Feuerstetin et al, 1988), and thus such studies might be enhanced.…”
Section: Discussionmentioning
confidence: 99%